Role of the leukemia-inhibitory factor gene mutations in infertile women: The embryo-endometrial cytokine cross talk during implantation - A delicate homeostatic equilibrium

Folia Microbiologica

Volumn 50, Issue 3, 2005, Pages 179-186

  Kralickova, M ^a   Sima P ^b   Rokyta, Z ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27144532370     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931563     Document Type: Review

References (62)

1. ARCK P.: Stress and embryo implantation. J.Gynecol.Obstet.Biol.Reprod. (Paris) 33, S40-S42 (2004).
2. ARICI A., ENGIN O., ATTAR E., OLIVE D.L.: Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J.Clin.Endocrinol.Metab. 80, 1908-1915 (1995).
3. BASAK S., DUBANCHET S., ZOURBAS S., CHAOUAT G., DAS C.: Expression of pro-inflammatory cytokines in mouse blastocysts during implantation: modulation by steroid hormones. Am.J.Reprod.Immunol. 47, 2-11 (2002).
4. BEDECARRATS G.Y., LINHER K.D., JANOVICK J.A., BERANOVA M., KADA F., SEMINARA S.B., MICHAEL CONN P., KAISER U.B.: Four naturally occurring mutations in the human GnRH receptor affect ligand binding and receptor function. Mol.Cell.Endocrinol. 31, 51-64 (2003).
5. BEER A.E., KWAK J.Y., RUIZ J.E.: Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. Am.J.Reprod.Immunol. 35, 376-382 (1996).
6. BERANOVA M., OLIVEIRA L.M.B., BEDECARRATS G.Y., SCHIPANI E., VALLEJO M., AMMINI A.C., QUINTOS J.B., HALL J.E., MARTIN K.A., HAYES F.J., PITTELOUD N., KAISER U., CROWLEY W.F. Jr., SEMINARA S.B.: Incidence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J.Clin.Endocrinol.Metab. 86, 1580-1588 (2001).
7. BERGART A.M.: The experience of women in unsuccessful infertility treatment: what do patients need when medical intervention fails? Soc.Work Health Care 30, 45-69 (2000).
8. BORINI A., BULLETTI C., CATTOLI M., SERRAO L., POLLI V., ALFIERI S., FLAMIGNI C.: Use of recombinant leukemia inhibitory factor in embryo implantation. Ann.N.Y.Acad.Sci. 828, 157-161 (1997).
9. BORNSTEIN S.R., RUTKOWSKI H., VREZAS I.: Cytokines and steroidogenesis. Mol.Cell.Endocrinol. 215, 135-141 (2004).
10. BRANDT K.H., ZECH H.: Results of a prognosis study of in vitro fertilization after brief psychotherapy. Geburtshilfe Frauenheilkd. 52, 297-300 (1992).
11. CALUWAERTS S., PIJNENBORG R., LUYTEN C., KEITH J.C. Jr., VAN ASSCHE F.A.: Differential effects of IL-11 on rat blastocysts and decidua during the peri-implantation period. Am.J.Reprod.Immunol. 47, 231-241 (2002).
12. H2 dichotomy. J.Reprod. Immunol. 53, 241-256 (2002).
13. H2 paradigm? Immunol.Lett. 92, 207-214 (2004).
14. CHARNOCK-JONES D.D., SHARKEY A.M., FENSWICK P., SMITH S.K.: Leukemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implatation and the blastocyst contains mRNA for the receptor at this time. J.Reprod.Fertil. 101, 421-426 (1994).
15. CHEUNG L.P., LEUNG H.Y., BONGSO A.: Effect of supplementation of leukemia inhibitory factor and epidermal growth factor on murine embryonic development in vitro, implantation, and outcome of offspring. Fertil.Steril. 80 (Suppl. 2), 727-735 (2003).
16. CULLINAN E.B., ABONDANZO S.J., ANDERSON P.S., POLLARD J.W., LESSEY B.A., STEWARD C.L.: Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation. Proc.Nat.Acad.Sci.USA 93, 3115-3120 (1996).
17. DELAGE G., MOREAU J.F., TAUPIN J.L., FREITAS S., HAMBARTSOUMIAN E., OLIVENNES F., FANCHIN R., LETUR-KONIRSCH H., FRYDMAN R., CHAOUAT G.: In-vitro endometrial secretion of human interleukin for DA cells/leukemia inhibitory factor by explant cultures from fertile and infertile women. Human Reprod. 10, 2483-2488 (1995).
18. DOMINGUEZ F., PELLICER A., SIMON C.: The chemokine connection: hormonal and embryonic regulation at the human maternal-embryonic interface - a review. Placenta 24 (Suppl. B), S48-S55 (2003).
19. DUNN C.L., CRITCHLEY H.O., KELLY R.W.: IL-15 regulation in human endometrial stromal cells. J.Clin.Endocrinol.Metab. 87, 1898-1901 (2002).
20. ENDERS A.C., MEAD R.A.: Progression of trophoblast into the endometrium during implantation in the western spotted skunk. Anat. Rec. 244, 297-315 (1996).
21. GAO J.Q., TSUDA Y., KATAYAMA K., NAKAYAMA T., HATANAKA Y., TANI Y., MIZUGUCHI H., HAYAKAWA T., YOSHIE O., TSUTSUMI Y., MAYUMI T., NAKAGAWA S.: Antitumor effect by interleukin-11 receptor α-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector. Cancer Res. 63, 4420-4425 (2003).
22. GIESS R., TANASESCU I., STECK T., SENDTNER M.: Leukemia inhibitory factor gene mutations in infertile women. Mol.Hum.Reprod. 5, 581-586 (1999).
23. GUBBAY O., CRITCHLEY H.O., BOWEN J.M., KING A., JABBOUR H.N.: Prolactin induces ERK phosphorylation in epithelial and CD56(+) natural killer cells of the human endometrium. J.Clin.Endocrinol.Metab. 87, 2329-2335 (2002).
24. HAINES B.P., VOYLE R.B., PELTON T.A., FORREST R., RATHIEN P.D.: Complex conserved organization of the mammalian leukemia inhibitory factor gene: regulated expression of intracellular and extracellular cytokines. J.Immunol. 162, 4637-4646 (1999).
25. HAMBARTSOUMIAN E.: Endometrial leukemia inhibitory factor (LIF) as a possible cause of unexplained infertility and multiple failures of implantation. Am.J.Reprod.Immunol. 39, 137-143 (1998).
26. HERRLER A., VON RANGO U., BEIER H.M.: Embryo-maternal signaling: how the embryo starts talking to its mother to accomplish implantation. Reprod.Biomed.Online 6, 244-256 (2003).
27. JOKHI P.P., KING A., SHARKEY A.M., SMITH S.K., LOKE Y.W.: Screening for cytokine messenger ribonucleic acids in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction. J.Immunol. 153, 4427-4435 (1994).
28. KELTZ M.D., ATTAR E., BURADAQUNTA S., OLIVE D.L., KLIMAN H.J., ARICI A.: Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in the human fallopian tube. Am.J.Obstet.Gynecol. 175, 1611-1619 (1996).
29. KLENTZERIS L.D., BULMER J.N., WARREN M.A., MORRISON L., LI T.C., COOKE I.D.: Lymphoid tissue in the endometrium of women with unexplained infertility: morphometric and immunohistochemical aspects. Human Reprod. 9, 646-652 (1994).
30. KOJIMA K., KANZAKI K., IWAI M., HATAYAMA H., FUJIMOTO M., INOUE T., HORIE K., NAKAYAMA H., FUJITA J., MORI T.: Expression of leukemia inhibitory factor in human endometrium and placenta. Biol.Reprod. 50, 882-887 (1994).
31. KRÁLÍČKOVÁ M., ŠÍMA P., ROKYTA Z., ULČOVÁ-GALLOVÁ Z., SUCHA R., UHER P., VANĚČEK T., ŠÍMA R., HES O.: Leukemia inhibitory factor gene mutations in the population of infertile women are not restricted to nulligravid patients. Europ.J.Obstet.Gynecol., in press (2005).
32. KRUSSEL J.S., BIELFELD P., POLAN M.L., SIMON C.: Regulation of embryonic implantation. Eur.J.Obstet.Gynecol.Reprod.Biol. 110 (Suppl. 1), S2-S9 (2003).
33. KUBRYCHT J., MALÍKOVÁ P., HUAN N.H., FIŠEROVA A., BEZOUŠKA K., KRUŽÍK P., STAJNER K., MORAVEC V., POSPÍŠIL M.: Peripheral membrane molecules of leukocytes and NK cytotoxicity. Folia Microbiol. 38, 421-431 (1993).
34. LAIRD S.M., TUCKERMAN E.M., DALTON C.F., DUNPHY B.C., LI T.C., ZHANG T.: The production of leukemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Human Reprod. 12, 569-574 (1997).
35. LE BOUTEILLER P.: The role of HLA-G expression in the embryo during implantation. J.Gynecol.Obstet.Biol.Reprod.(Paris) 33, S9-S12 (2004).
36. LEDEE-BATAILLE N., KOEPPEL B., FRYDMAN R., CHAOUAT G.: The impact of stress in the matemofetal relationship: an immunological approach. Gynecol.Obstet.Fertil. 31, 778-781 (2003).
37. LEDEE-BATAILLE N., DUBANCHET S., COULOMB-L'HERMINE A., DURAND-GASSELIN I., FRYDMAN R., CHAOUAT G.: A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro fertilization. Fertil.Steril. 81, 59-65 (2004a).
38. LEDEE-BATAILLE N., OLIVENNES F., KADOCH J., DUBANCHET S., FRYDMAN N., CHAOUAT G., FRYDMAN R.: Detectable levels of interleukin-18 in uterine luminal secretions at oocyte retrieval predict failure of the embryo transfer. Human Reprod. 19, 1968-1973 (2004b).
39. LEI T., YANG Z.Q., XIA T., GAN L., CHEN X.D., YUAN J.H., ZHU Y.: Stage-specific expression of leukemia inhibitory factor and its receptor in rabbit pre-implantation embryo and uterine epithelium during early pregnancy. Reprod.Domest.Anim. 39, 13-18 (2004).
40. METCALF D.: The unsolved enigmas of leukemia inhibitory factor. Stem Cells 21, 5-14 (2003).
41. MIKOLAJCZYK M., SKRZYPCZAK J., SZYMANOWSKI K., WIRSTLEIN P.: The assessment of LIF in uterine flushing - a possible new diagnostic tool in states of impaired fertility. Reprod.Biol. 3, 259-270 (2003).
42. MOFFETT-KING A.: Natural killer cells and pregnancy. Nature Rev.Immunol. 2, 656-663 (2002).
43. NARDO L.G., NIKAS G., MAKRIGIANNAKIS A.: Molecules in blastocyst implantation. Role of matrix metalloproteinases, cytokines and growth factors. J.Reprod.Med. 48, 137-147 (2003).
44. H2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss. J.Reprod.Immunol. 52, 35-43 (2001).
45. ROBB L., DIMITRIADIS E., LI R., SALAMONSEN L.A.: Leukemia inhibitory factor and interleukin-11: cytokines with key roles in implantation. J.Reprod.Immunol. 57, 129-141 (2002).
46. ROMERO R., ESPINOZA J., MAZOR M.: Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil.Steril. 82, 799-804 (2004).
47. bright natural killer cells in the human early pregnancy decidua. Internat.Immunol. 5, 559-563 (1993).
48. SCHOFIELD G., KIMBER S.J.: Leukocyte subpopulations in the uteri of leukemia inhibitory factor knockout mice during early pregnancy. Biol.Reprod. 72, 872-878 (2005).
49. SHARKEY A.M., KING A., CLARK D.E., BURROWS T.D., JOKHI P.P., CHARNOCK-JONES D.S., LOKE Y.W., SMITH S.K.: Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy. Biol.Reprod. 60, 355-364 (1999).
50. SHERWIN J.R., SMITH S.K., WILSON A., SHARKEY A.M.: Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility. J.Clin.Endocrinol.Metab. 87, 3953-3960 (2002).
51. SHERWIN J., FREEMAN T., STEPHENS R., KIMBER S., SMITH A., CHAMBERS I., SMITH S., SHARKEY A.: Identification of genes regulated by leukaemia inhibitory factor in the mouse uterus at the time of implantation. Mol.Endocrinol. 18, 2185-2195 (2004).
52. SIRISATHIEN S., HERNANDEZ-FONSECA H.J., BOSCH P., HOLLET B.R., LOTT J.D., BRACKETT B.G.: Effect of leukemia inhibitory factor on bovine embryos produced in vitro under chemically defined conditions. Theriogenology 59, 1751-1763 (2003).
53. ŠPLÍCHAL I., TREBICHAVSKÝ I.: Cytokines and other important inflammatory mediators in gestation and bacterial intraamniotic infections. Folia Microbiol. 46, 345-351 (2001).
54. STAHL J., GEARING D.P., WILLSON T.A., BROWN M.A., KING J.A., GOUGH N.M.: Structural organization of the genes for murine and human leukemia inhibitory factor. Evolutionary conservation of coding and noncoding regions. J.Biol.Chem. 265, 8833-8841 (1990).
55. STECK T., GIESS R., SUETTERLIN M.W., HOLLAND M., WIEST S., POEHLS U.G., DIETL J.: Leukemia inhibitory factor (LIF) gene mutations in women with unexplained infertility and recurrent failure of implantation after IVF and embryo transfer. Eur. J.Obstet.Gynecol.Reprod.Biol. 112, 69-73 (2004).
56. STEWART C.L., KASPAR P., BRUNET L.J., BHATT H., GADI I., KONTGEN F., ABBONDANZO S.J.: Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 359, 76-79 (1992).
57. STEWART C.L.: Leukemia inhibitory factor and the regulation of pre-implantation development of the mammalian embryo. Mol.Reprod. Dev. 39, 233-238 (1994).
58. TABIBZADEH S.: Molecular control of the implantation window. Human Reprod. Update 4, 465-471 (1998).
59. TSAI H.D., CHANG C.C., HSIEH Y.Y., LO H.Y.: Leukemia inhibitory factor expression in different endometrial locations between fertile and infertile women throughout different menstrual phases. Assist.Reprod.Genet. 17, 415-418 (2000).
60. VOGIAGIS D., MARSH M.M., FRY R.C., SALAMONSEN L.A.: Leukemia inhibitory factor in human endometrium throughout the menstrual cycle. J.Endocrinol. 148, 95-102 (1996).
61. VOGIAGIS D., SALAMONSEN L.A.: Review: the role of leukemia inhibitory factor in the establishment of pregnancy. J.Endocrinol. 160, 181-190 (1999).
62. WILLSON T.A., METCALF D., GOUGH N.M.: Cross-species comparison of the sequence of the leukemia inhibitory factor gene and its protein. Eur.J.Biochem. 204, 21-30 (1992).